Active Ingredient (In Each Tablet)
Dimenhydrinate 50 mg
Motion Sickness Tablet
FDA Label NDC 70677-1087
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Strategic Sourcing Services Llc for the product Motion Sickness (NDC 70677-1087). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, when using this product, if pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Purpose
Antiemetic
Uses
for prevention and treatment of these symptoms associated with motion sickness:
- nausea
- vomiting
- dizziness
Do Not Use
for children under 2 years of age unless directed by a doctor.
Ask A Doctor Before Use If You Have
- a breathing problem such as emphysema or chronic bronchitis
- glaucoma
- difficulty in urination due to enlargement of the prostate gland
Ask A Doctor Or Pharmacist Before Use If You Are
taking sedatives or tranquilizers.
When Using This Product
- alcohol, sedatives, and tranquilizers may increase drowsiness
- marked drowsiness may occur
- use caution when driving a motor vehicle or operating machinery
- avoid alcoholic beverages
If Pregnant Or Breast-Feeding,
ask a health professional before use.
Keep Out Of Reach Of Children.
In case of overdose, get medical help or contact a Poison Control Center right away.
Directions
- to prevent motion sickness, the first dose should be taken one-half to one hour before starting activity
| adults and children 12 years and over | 1 to 2 tablets every 4-6 hours; do not exceed 8 tablets in 24 hours, or as directed by a doctor |
| children 6 to under 12 years | ½ to 1 tablet every 6-8 hours; do not exceed 3 tablets in 24 hours, or as directed by a doctor |
| children 2 to under 6 years | ½ tablet every 6-8 hours; do not exceed 1½ tablets in 24 hours, or as directed by a doctor |
Other Information
- each tablet contains: calcium 35 mg
- TAMPER EVIDENT: DO NOT USE IF OUTER PACKAGE IS OPENED OR BLISTER IS TORN OR BROKEN
- store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F)
- protect from moisture
- see end flap for expiration date and lot number
Inactive Ingredients
croscarmellose sodium, dibasic calcium phosphate dihydrate, magnesium stearate, microcrystalline cellulose, silicon dioxide, stearic acid
Questions Or Comments?
Call 833-358-6431 Monday to Friday 9:00am to 7:00pm EST
Principal Display Panel
NDC 70677-1087-1
COMPARE TO DRAMAMINE®
ORIGINAL FORMULA ACTIVE INGREDIENT*
Foster & Thrive™
Motion Sickness
Dimenhydrinate 50 mg
ANTIEMETIC
Prevents:
• Nausea • Vomiting • Dizziness
for Children & Adults
ACTUAL SIZE
12 TABLETS
*This product is not manufactured or distributed by Medtech Products Inc.,
owner of the registered trademark Dramamine® Original Formula.
50844 ORG051819802 Rev. 03/23
Distributed by: McKesson Corp., via Strategic Sourcing
Services LLC., Memphis, TN 38141
Money Back Guarantee
www.fosterandthrive.com
©2023 McKesson Corporation
TAMPER EVIDENT: DO NOT USE IF PACKAGE IS
OPENED OR IF BLISTER UNIT IS TORN, BROKEN
OR SHOWS ANY SIGNS OF TAMPERING
Foster And Thrive 44-198 (Foster And Thrive 44 198 1) 
* Please review the disclaimer below.
